The Academy of Pharmaceutical Sciences

Perrigo 2Q profit doubles without write-down

Biotechnology company Amgen Inc. said Monday its profit rose 1 percent in the fourth quarter, as the company reported mixed results for its anemia drugs, but said sales of its other drugs held steady.

Northrop posts 4Q profit on higher sales

Defense contractor Northrop Grumman Corp. said Thursday it posted a fourth-quarter profit of $413 million in contrast to a year-ago loss as sales rose 2 percent.

Teva Pharma Settles Some Medicaid Drug Price Suits

Teva Pharmaceutical Industries Ltd., the world's largest generic drugmaker, said Friday it is settling several lawsuits related to Medicaid reimbursement for its products, and is setting aside $315 million to cover the settlement and other suits.

Earnings Preview: CVS Caremark to report 4Q

Friday, February 5, 2010 at 7:46 a.m. WOONSOCKET, R.I. - Drugstore operator and pharmacy benefits manager CVS Caremark Corp.

Biocon and Bayer Join Hands to Create Awareness for Self Monitoring in Diabetics

Bangalore, Karnataka, India, Thursday, February 04, 2010 -- Biocon and Bayer Healthcare, a subsidiary of Bayer AG, one of the worldA's leading, innovative companies in the healthcare and medical products industry; have entered into a strategic partnership to fight the diabetes menace in India.

Achillion's New Shares Raise $22.9M

Achillion Pharmaceuticals Inc. said Tuesday that it has raised $22.9 million from its recent sale of additional shares of common stock.

Arrest Log 02-02-10

Tuesday, February 02, 2010 Panola County Arrest Log 02-02-10 The following information was taken from the log book at the David M. Bryan Justice Complex.

Teva Announces FDA Accepts BLA for XM02

Feb 2, 2010 - Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has accepted for filing Teva's Biologics License Application for XM02, a granulocyte colony-stimulating factor for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with ...

Watson to become commercial partner for emergency contraceptive

MORRISTOWN,A N.J. Watson Pharmaceuticals and HRA Pharma have signed a deal whereby Watson will become the commercial partner for an emergency contraceptive undergoing regulatory review by the Food and Drug Administration, Watson announced Monday.

News and FDA Updates for Gilead

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

Cardinal closing ends jobs for 115

Cardinal Health plans to close its Findlay, Ohio, distribution center in April, a move that will put about 115 employees out of work, the company said yesterday.

Bayer to Discontinue Phase II Clinical Trial for Long-Acting...

Bayer Schering Pharma AG, Germany has announced that an independent Data Safety and Monitoring Board has completed an interim analysis of a phase II trial of the company's long-acting recombinant factor VIII, BAY79-4980. The DSMB concluded that the study will not be able to achieve the predetermined efficacy endpoint .

Time Warner Cable posts profit but outlook low

Time Warner Cable Inc. reported a profit for the fourth quarter Thursday but the economy was still weighing on its customers, who cut back on their subscriptions of premium movie channels and ordered fewer videos on demand.